Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
101497803 | 10149780 | 3 | F | 20140415 | 20160523 | 20140502 | 20160630 | PER | US-JNJFOC-20140419635 | JANSSEN | 86.99 | YR | E | F | Y | 0.00000 | 20160630 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
101497803 | 10149780 | 1 | PS | XARELTO | RIVAROXABAN | 1 | Oral | MAY BE 2013 ^NOT SURE^ | N | UNKNOWN | 22406 | TABLET | |||||||
101497803 | 10149780 | 2 | C | TRIBENZOR | AMLODIPINE BESYLATEHYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
101497803 | 10149780 | 3 | C | SOTALOL. | SOTALOL | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
101497803 | 10149780 | 1 | Product used for unknown indication |
101497803 | 10149780 | 2 | Blood pressure abnormal |
101497803 | 10149780 | 3 | Atrial fibrillation |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
101497803 | 10149780 | OT |
101497803 | 10149780 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
101497803 | 10149780 | Gastric ulcer haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
101497803 | 10149780 | 1 | 201203 | 20140414 | 0 |